159 related articles for article (PubMed ID: 33717406)
1. Vigabatrin-associated Reversible MRI Abnormalities in an Infant with Tuberous Sclerosis.
Craft JF; Cardenas AM
J Radiol Case Rep; 2021 Feb; 15(2):1-6. PubMed ID: 33717406
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin-associated diffusion MRI abnormalities in tuberous sclerosis.
Thapa M; Khanna PC
Pediatr Radiol; 2010 Dec; 40 Suppl 1():S153. PubMed ID: 20931331
[No Abstract] [Full Text] [Related]
3. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin-related magnetic resonance imaging abnormalities in an infant with tuberous sclerosis complex and infantile spasms.
Hsieh DT; Thiele EA
J Pediatr; 2013 Jan; 162(1):215. PubMed ID: 22979977
[No Abstract] [Full Text] [Related]
5. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
van der Poest Clement EA; Sahin M; Peters JM
J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
[TBL] [Abstract][Full Text] [Related]
6. Elevation of brain gamma-aminobutyric acid levels is associated with vigabatrin-associated brain abnormalities on magnetic resonance imaging.
Ikeda A; Tomiyasu M; Yamamoto A; Tsuyusaki Y; Kawai Y; Tanabe M; Tsuji M; Iai M; Aida N; Goto T
Epilepsy Res; 2022 Mar; 181():106881. PubMed ID: 35183975
[TBL] [Abstract][Full Text] [Related]
7. [Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis].
Rotta NT; da Silva AR; Ohlweiler L; Riesgo R
Arq Neuropsiquiatr; 2003 Dec; 61(4):988-90. PubMed ID: 14762603
[TBL] [Abstract][Full Text] [Related]
8. Steroids or vigabatrin in the treatment of infantile spasms?
Riikonen RS
Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.
Chiron C; Dumas C; Jambaqué I; Mumford J; Dulac O
Epilepsy Res; 1997 Jan; 26(2):389-95. PubMed ID: 9095401
[TBL] [Abstract][Full Text] [Related]
10. Autistic regression associated with seizure onset in an infant with tuberous sclerosis.
Humphrey A; Neville BG; Clarke A; Bolton PF
Dev Med Child Neurol; 2006 Jul; 48(7):609-11. PubMed ID: 16780633
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
Hancock E; Osborne JP
J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
[TBL] [Abstract][Full Text] [Related]
12. Preventive Antiepileptic Treatment in Tuberous Sclerosis Complex: A Long-Term, Prospective Trial.
Jozwiak S; Słowińska M; Borkowska J; Sadowski K; Łojszczyk B; Domańska-Pakieła D; Chmielewski D; Kaczorowska-Frontczak M; Głowacka J; Sijko K; Kotulska K
Pediatr Neurol; 2019 Dec; 101():18-25. PubMed ID: 31481332
[TBL] [Abstract][Full Text] [Related]
13. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
14. Cerebral MRI abnormalities associated with vigabatrin therapy.
Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
[TBL] [Abstract][Full Text] [Related]
15. Visual field constriction on vigabatrin.
Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
[TBL] [Abstract][Full Text] [Related]
16. The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex.
Whitney R; Jan S; Zak M; McCoy B
Pediatr Neurol; 2017 Jul; 72():76-80. PubMed ID: 28506505
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
[TBL] [Abstract][Full Text] [Related]
18. Risk of vigabatrin-associated brain abnormalities on MRI: A retrospective and controlled study.
Xu Y; Wan L; He W; Wang YY; Wang QH; Luo XM; Liu K; Yang XY; Wang J; Shi XY; Yang G; Han F; Gao J; Zou LP
Epilepsia; 2022 Jan; 63(1):120-129. PubMed ID: 34786694
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
Camposano SE; Major P; Halpern E; Thiele EA
Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
[TBL] [Abstract][Full Text] [Related]
20. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
Dill P; Datta AN; Weber P; Schneider J
Eur J Paediatr Neurol; 2013 May; 17(3):311-5. PubMed ID: 23199677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
